seed
Stage
About
Permeasis develops a proprietary membrane translocation domain platform to enable intracellular delivery of therapeutic proteins and macromolecules, aiming to address diseases inaccessible to conventional biologics or small molecules.
Explore Permeasis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.